Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Apr 02, 2021 10:07am
76 Views
Post# 32931764

RE:New BUY rating by the way / price target 11$

RE:New BUY rating by the way / price target 11$Stups, try to make sense bud.

Analysts go from $22 to $11 is not a good thing,  Also, remember the one analyst from Piper Sandler had $22, but we all know Piper acted as TV agent for private placement.

Now you claim "triple boost" coming and they cut their 12 month target in half.  IN HALF after a triple boost?  LOL quite the boost.

What do analysts know that you obviously don't, to cut the price in half.

Your desperate and no credibility.


Newcamo wrote: certainly conservative but it's a start..

LMNL Analyst Ratings

Consensus Buy

Based on 4 analysts offering recommendations for lmnl in the last 3 months.

Analyst Firms Making Recommendations

  • BLOOM BURTON&CO
  • ECHELON WEALTH
  • H C WAINWRIGHT
  • PIPER SANDLER

Analyst

$11

https://www.nasdaq.com/market-activity/stocks/lmnl/analyst-research


<< Previous
Bullboard Posts
Next >>